Hester Biosciences Limited (HESTERBIO) Financial Statements

0 Followers

Hester Biosciences Limited Financial Overview

Hester Biosciences Limited's market cap is currently ₹15.65B. The company's EPS TTM is ₹52.41; its P/E ratio is 18.63; and it has a dividend yield of 0.44%. Hester Biosciences Limited is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 3.33B	₹ 3.11B	₹ 3.05B	₹ 2.66B	₹ 2.35B
Gross Profit	₹ 1.69B	₹ 2.08B	₹ 972.64M	₹ 1.89B	₹ 1.66B
Operating Income	₹ 677.77M	₹ 455.05M	₹ 364.77M	₹ 310.27M	₹ 1.25B
EBITDA	₹ 866.58M	₹ 649.76M	₹ 582.46M	₹ 619.20M	₹ 731.93M
Net Income	₹ 556.39M	₹ 274.88M	₹ 188.89M	₹ 266.27M	₹ 393.20M
Balance Sheet
Cash & Short-Term Investments	₹ 65.38M	₹ 72.19M	₹ 153.04M	₹ 148.17M	₹ 252.20M
Total Assets	₹ 6.78B	₹ 6.53B	₹ 6.62B	₹ 6.70B	₹ 5.62B
Total Debt	₹ 1.95B	₹ 2.13B	₹ 2.44B	₹ 2.74B	₹ 2.28B
Net Debt	₹ 1.88B	₹ 2.06B	₹ 2.32B	₹ 1.60B	₹ 2.04B
Total Liabilities	₹ 3.10B	₹ 3.27B	₹ 3.59B	₹ 3.81B	₹ 2.95B
Stockholders' Equity	₹ 3.60B	₹ 3.14B	₹ 2.92B	₹ 2.80B	₹ 2.60B
Cash Flow
Free Cash Flow	₹ 417.03M	₹ 439.20M	₹ 237.37M	₹ -541.66M	₹ -869.02M
Operating Cash Flow	₹ 595.31M	₹ 645.11M	₹ 481.34M	₹ 235.96M	₹ 88.08M
Investing Cash Flow	₹ -49.00M	₹ -190.03M	₹ -226.54M	₹ -769.99M	₹ -1.17B
Financing Cash Flow	₹ -421.53M	₹ -517.17M	₹ -260.45M	₹ 417.58M	₹ 1.12B

Currency in INR

Hester Biosciences Limited Earnings and Revenue History

Income Statement >

Hester Biosciences Limited Debt to Assets

Balance Sheet >

Hester Biosciences Limited Cash Flow

Cash Flow >

Hester Biosciences Limited Forecast EPS vs Actual EPS

Earnings >